Gene · 3047
Papers4,047
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,047
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A differentiated β-globin gene replacement strategy uses heterologous introns to restore physiological expression. | Mol Ther | 2025 | 40022449 | PubTator, text mining | PubMed |
| Exploratory Review and In Silico Insights into circRNA and RNA-Binding Protein Roles in γ-Globin to β-Globin Switching. | Cells | 2025 | 39996784 | PubTator, text mining | PubMed |
| Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working Group. | Mol Ther Nucleic Acids | 2025 | 39991472 | PubTator, text mining | PubMed |
| Systematic identification and validation of ceRNA-driven regulatory mechanisms in pediatric β-Thalassemia major. | Ann Hematol | 2025 | 39930261 | PubTator, text mining | PubMed |
| Impact of Xmn1 polymorphism on hydroxyurea therapy in children with HbE-β non-transfusion dependent thalassemia: a cohort study. | Clin Exp Pediatr | 2025 | 39901718 | PubTator, text mining | PubMed |
| High-accuracy crRNA array assembly strategy for multiplex CRISPR. | Mol Ther Nucleic Acids | 2025 | 39897580 | PubTator, text mining | PubMed |
| TFII-I/GTF2I regulates globin gene expression and stress response in erythroid cells. | J Biol Chem | 2025 | 39864622 | PubTator, text mining | PubMed |
| Dias-Logan syndrome with a de novo p.Leu360Profs*212 heterozygous pathogenic variant of BCL11A in a Chinese patient: A case report. | SAGE Open Med Case Rep | 2025 | 39835253 | PubTator, text mining | PubMed |
| Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics. | Chem Rev | 2025 | 39818743 | PubTator, text mining | PubMed |
| MYB represses ζ-globin expression through upregulating ETO2. | Acta Biochim Biophys Sin (Shanghai) | 2025 | 39757769 | PubTator, text mining | PubMed |
| Prenatal Exome Sequencing Identifies Dual Maternal-Fetal Diagnosis of HbF Mission Bay, a Novel HBG2 Variant Associated With Methemoglobinemia, Hypoxia and Hemolytic Anemia. | Prenat Diagn | 2025 | 39746815 | PubTator, text mining | PubMed |
| Haplotype-Resolved Genotyping and Association Analysis of 1,020 β-Thalassemia Patients by Targeted Long-Read Sequencing. | Adv Sci (Weinh) | 2025 | 39737841 | PubTator, text mining | PubMed |
| The role of miR-129-5p in regulating γ-globin expression and erythropoiesis in β-thalassemia. | Hum Mol Genet | 2025 | 39657657 | PubTator, text mining | PubMed |
| Activation of γ-globin expression by a common variant disrupting IKAROS-binding motif in β-thalassemia. | J Genet Genomics | 2025 | 39521044 | PubTator, text mining | PubMed |
| Upregulation of miR‑6747‑3p affects red blood cell lineage development and induces fetal hemoglobin expression by targeting BCL11A in β‑thalassemia. | Mol Med Rep | 2025 | 39450557 | PubTator, text mining | PubMed |
| Fateful Decisions of Where to Cut the Line: Pathology Associated with Aberrant 3' End Processing and Transcription Termination. | J Mol Biol | 2025 | 39321865 | PubTator, text mining | PubMed |
| D-SPIN constructs gene regulatory network models from multiplexed scRNA-seq data revealing organizing principles of cellular perturbation response. | bioRxiv | 2025 | 37131803 | PubTator, text mining | PubMed |
| Hydroxyurea reduces the levels of the fetal globin gene repressors ZBTB7A/LRF and BCL11A in erythroid cells in vitro. | J Sick Cell Dis | 2024 | 40304012 | PubTator, text mining | PubMed |
| Enhanced fetal hemoglobin production via dual-beneficial mutation editing of the HBG promoter in hematopoietic stem and progenitor cells for β-hemoglobinopathies. | Stem Cell Res Ther | 2024 | 39736768 | PubTator, text mining | PubMed |
| Revisiting γ-globin gene repression by TR4. | Blood | 2024 | 39724166 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3047/papers?page=7